Perinatology.com — Inpatient Order Set Module (Template)

IUFD / Stillbirth — Inpatient / L&D Order Set (Example)

For use by OB/GYN, MFM, L&D nursing, ED, anesthesia, pathology, and bereavement teams. Print-optimized for chart inclusion; each bullet can be mapped to discrete EHR orders.

Population: confirmed or suspected IUFD / stillbirth Goals: maternal safety + compassionate care + targeted evaluation Site-adaptable checklist + orders
Patient Name / MRN: ___________________________
Gestational age GA: _______ w _______ d
Date/Time Dx: ____/____/_____ ________
Clinician ___________________________
Safety note: This is an educational template. Verify medication choices/doses and local orderable names. Tailor to patient factors (GA, prior uterine surgery, infection/abruption, preeclampsia, bleeding, Rh status) and institutional policy.

1. Confirmation, Triage & Immediate Support

2. Location, Monitoring, IV Access

3. Maternal Labs & Diagnostic Studies

Admission / STAT (common)

  • ☐ CBC with platelets
  • ☐ Type & screen (or type & crossmatch ____ units PRBCs if high hemorrhage risk)
  • ☐ CMP (electrolytes, renal function, LFTs as indicated)
  • ☐ Urinalysis ± culture (if infection suspected)

Coagulopathy / abruption / severe features (select as indicated)

  • ☐ PT/INR, aPTT
  • ☐ Fibrinogen
  • ☐ D-dimer (if part of local DIC panel)
  • Consider baseline coagulation testing when there is significant bleeding, suspected abruption, sepsis, severe preeclampsia/HELLP, or prolonged retention per local practice.

Recommended maternal evaluation at time of demise (ACOG/SMFM OCC #10)

  • ☐ Fetomaternal hemorrhage screen: Kleihauer–Betke or flow cytometry (send as soon as possible after diagnosis)
  • ☐ Syphilis testing
  • ☐ Antiphospholipid antibody testing:
    • ☐ Lupus anticoagulant
    • ☐ Anticardiolipin IgG/IgM
    • ☐ Anti–β2-glycoprotein I IgG/IgM
  • Do not order routine inherited thrombophilia testing as part of stillbirth evaluation (unless specific clinical indication).

Additional tests only if indicated by history/presentation

  • ☐ Glucose screen / HbA1c (if not known or LGA/macrosomia concern)
  • ☐ Toxicology screen (if abruption or substance use suspected)
  • ☐ Preeclampsia evaluation (as indicated): urine protein/creatinine, uric acid, etc.
  • Routine TORCH serologies are generally not recommended unless specific suspicion; consult MFM/pathology for targeted infectious testing.

4. Delivery Planning (Shared Decision Making)

5. Induction Orders (Select Local Protocol Defaults)

Uterotonic / cervical ripening options

  • ☐ Misoprostol regimen per GA and local protocol
    • ACOG/SMFM OCC #10 notes that before 28 weeks, typical misoprostol dosing for stillbirth induction has been 400–600 micrograms vaginally every 3–6 hours; after 28 weeks, manage per usual obstetric induction protocols.
    • If prior uterine scar and 24–28 weeks, consider lower-dose strategy per local protocol; after 28 weeks with prior hysterotomy, follow TOLAC induction protocols (avoid routine misoprostol).
  • ☐ High-dose oxytocin infusion per local protocol (acceptable alternative in some cases)
  • ☐ Mechanical ripening (e.g., transcervical balloon) per local protocol (especially ≥28 weeks or prior scar per policy)
  • ☐ Consider mifepristone adjunct (where available) per local protocol (commonly given 24–48 hours before misoprostol in some pathways)

Rupture of membranes

  • ☐ AROM when appropriate and safe (per cervical exam, presentation, and provider judgment)

Antibiotics (only if indicated)

  • ☐ No antibiotics (routine prophylaxis not indicated)
  • ☐ Start antibiotics for suspected/confirmed infection (chorioamnionitis, sepsis, etc.) per local pregnancy-safe regimen
  • ☐ GBS prophylaxis: ☐ not indicated ☐ per local policy (rare scenarios)

Hemorrhage preparedness (select as indicated)

  • ☐ Hemorrhage cart available / PPH protocol awareness
  • ☐ TXA availability per local protocol
  • ☐ Uterotonics available postpartum per standard practice
  • ☐ Active management of 3rd stage per protocol

6. Analgesia, Sedation & Supportive Care

7. Rh, Blood Bank, and Post-Delivery Maternal Care

8. Fetal/Placental Evaluation & Specimen Handling

9. Documentation, Legal/Reporting, Disposition

10. Discharge Planning & Follow-Up

References (Key Sources)